<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02856308</url>
  </required_header>
  <id_info>
    <org_study_id>HET-03</org_study_id>
    <nct_id>NCT02856308</nct_id>
  </id_info>
  <brief_title>Hairstetics Hair Implant Device Safety and Efficacy</brief_title>
  <official_title>Safety and Efficacy Evaluation of Hairstetics Hair Implant in Subjects Affected With Hair Loss - a Clinical Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hairstetics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hairstetics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, single-arm, multi-center, international, open-label, non-randomized,
      clinical study.

      The aim of the study is to assess the safety and efficacy of the use of the Hairstetics hair
      implant device in subjects affected with hair loss.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Acceptable number, duration and severity of expected adverse device/procedure effects</measure>
    <time_frame>3 months following implantation</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Alopecia</condition>
  <arm_group>
    <arm_group_label>Hairstetics hair implant device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will undergo the Hairstetics prosthetic hair implantation starting with a test of up to 100 fibers and up to 2 additional implantation sessions with up to 1500 fibers overall per subject. The implantation will be carried out according to the device IFU.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hairstetics hair implant device</intervention_name>
    <arm_group_label>Hairstetics hair implant device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject is ≥ 19 years old.

          2. Subject has hair loss and has chosen to undergo synthetic hair implantation.

          3. Subject has mental capacity to understand study guidelines and requirements (to
             maintain scalp hygiene, use of shampoo, delicate combing, etc.).

          4. Subject has been evaluated by the investigator to have a scalp condition in the
             planned area of implantation that is acceptable for entering the study and currently
             is NOT suffering from skin problems at planned implantation site or elsewhere that
             might affect the procedure and/or success as clinically evaluated by the investigator.

          5. Subject has Good general health.

          6. Woman of child bearing potential must have a negative pregnancy test.

          7. Subject willing to sign a written informed consent form (ICF) and the post
             implantation maintenance protocol.

        Exclusion Criteria:

          1. Previous synthetic hair implantation or hair transplantation in the past 6 months.

          2. Currently suffering from skin problems at planned implantation site or elsewhere that
             might affect the procedure and/or success as clinically evaluated by the investigator.

          3. Currently receiving or have within the past 3 months received radiation- and/or
             chemotherapy.

          4. Currently using steroid product with Immunosuppressive treatment.

          5. Impaired coagulation.

          6. Serious illness that may affect subject compliance to protocol.

          7. Subject is using illegal drugs.

          8. Participating in other clinical study.

          9. Known allergy or hypersensitivity to Nitinol or Nickel or Titanium

         10. For woman: Pregnancy or breast feeding.

         11. Known allergy or intolerance for the prescribed antibiotics and in such a case, a
             different antibiotics for which the subject is not allergic or intolerance to, will be
             prescribed
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Igal Ruvinsky, PhD</last_name>
    <phone>+972-72-2501630</phone>
    <email>igal.r@hairstetics.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Boaz Shenhav</last_name>
    <phone>+972-72-2501630</phone>
    <email>boaz.s@hairstetics.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cabinet du Dr G. Beilin</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ghislaine Beilin, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cabinet médical du Dr Jack Smadja</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jack Smadja, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Georges Mandel Office Surgery Clinic</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Divaris, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Paras hospital</name>
      <address>
        <city>Gurgaon</city>
        <zip>122002</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anil Ganjoo, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fortis Hospital</name>
      <address>
        <city>New Delhi</city>
        <zip>110088</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manjul Agrawal, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Egoclinic</name>
      <address>
        <city>Bucharest</city>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irinel Nedelcu, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Metropolitan hospital</name>
      <address>
        <city>Bucharest</city>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Radu Jecan, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Revere clinic</name>
      <address>
        <city>London</city>
        <zip>W1G7JA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sach Mohan, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
    <country>India</country>
    <country>Romania</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 7, 2016</study_first_submitted>
  <study_first_submitted_qc>August 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 4, 2016</study_first_posted>
  <last_update_submitted>August 8, 2017</last_update_submitted>
  <last_update_submitted_qc>August 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alopecia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

